Ms. Ivy Felice Garbowitz, MA CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 445 Central Avenue, Cedahurst, NY 11516 Phone: 516-374-3377 |
News Archive
Helix BioPharma today announced that it has received approval from Sweden's drug regulatory authority, the Medical Products Agency (MPA), to conduct a Phase II clinical trial of Topical Interferon Alpha-2b in patients with ano-genital warts (condylomata acuminata), who are positive for infection with the human papilloma virus (HPV).
It's 1 p.m. on a balmy Oakland afternoon as residents of Great Expectations Residential Care, a home for people with mental illness, gather in an activity room for a game of bingo.
Although a variety of nanoparticles continue to show promise for improving cancer imaging and therapy, regulators and drug developers are concerned that these delivery systems may prove difficult to manufacture on a consistent basis, which is key for any agent designed for use in humans.
Studies have shown that mortality rates in hospitalized patients with COVID-19 are high, ranging between 10% and 30%. REGEN-COVĀ®, a combination of monoclonal antibodies casirivimab and imdevimab, is approved in the United States and other regions for emergency treatment of COVID-19 outpatients with mild to moderate SARS-CoV-2 infection and post-exposure prophylaxis.
› Verified 6 days ago